BRIEF published on 09/03/2025 at 16:07, 1 year ago The Vanguard Group Discloses Deliveroo Stake Form 8.3 Takeover Code Securities Disclosure Vanguard Group Deliveroo
PRESS RELEASE published on 09/03/2025 at 16:06, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc The Vanguard Group, Inc. discloses a 3.51% ownership in Dalata Hotel Group plc as of September 2, 2025. No other disclosures made Irish Takeover Panel The Vanguard Group Ownership Disclosure Financial Disclosure Dalata Hotel Group Plc
BRIEF published on 09/03/2025 at 16:05, 1 year ago The Vanguard Group Discloses Position in Dowlais Group Form 8.3 Takeover Code Vanguard Group Investor Disclosure Dowlais Group
PRESS RELEASE published on 09/03/2025 at 16:05, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. makes an opening position disclosure related to Mural Oncology plc under Rule 8.3 of the Irish Takeover Panel Act for relevant securities representing 1% or more Opening Position Disclosure Irish Takeover Panel The Vanguard Group Rule 8.3 Mural Oncology Plc
BRIEF published on 09/03/2025 at 16:04, 1 year ago The Vanguard Group Reports Stake in Bakkavor Group plc The Vanguard Group Rule 8.3 Stake Disclosure Securities Interest Bakkavor Group Plc
PRESS RELEASE published on 09/03/2025 at 16:04, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses 5.35% ownership of Greencore Group plc shares. Additional disclosures for Bakkavor Group plc are also made The Vanguard Group, Greencore Group Plc, Ownership Disclosure, Bakkavor Group Plc, Financial Disclosure
BRIEF published on 09/03/2025 at 16:03, 1 year ago The Vanguard Group Publicly Discloses Position in Just Group plc Takeover Code Securities Disclosure Vanguard Group Investments Just Group Plc
PRESS RELEASE published on 09/03/2025 at 16:03, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Alphawave IP Group plc The Vanguard Group, Inc. discloses a 1.42% interest in Alphawave IP Group plc as per Form 8.3 filing Securities Form 8.3 Disclosure Vanguard Group Alphawave IP Group
BRIEF published on 09/03/2025 at 16:02, 1 year ago The Vanguard Group Discloses Position in NCC Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group NCC Group
PRESS RELEASE published on 09/03/2025 at 16:02, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Deliveroo plc The Vanguard Group, Inc. discloses a 3.92% position in Deliveroo plc's 0.5p ordinary securities. Purchase of 20,553 shares at 1.79 GBP per unit on 02 Sep 2025 Securities Position Disclosure The Vanguard Group Stock Purchase Deliveroo PLC
Published on 09/12/2026 at 02:35, 1 day 23 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 2 days 3 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 2 days 4 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 2 days 9 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 1 day 8 hours ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 18 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 2 days 3 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 2 days 3 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 2 days 6 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 19 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 3 days 6 hours ago Availability of the 2026 Interim Financial Report